Drug Information

Drug General Information
Drug ID
D0M0TS
Former ID
DNC013235
Drug Name
(2S)-aminobutyryl-L-proline (R)-sec-butylamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527857]
Structure
Download
2D MOL

3D MOL
Formula
C13H25N3O2
Canonical SMILES
CCC(C)NC(=O)C1CCCN1C(=O)C(CC)N
InChI
1S/C13H25N3O2/c1-4-9(3)15-12(17)11-7-6-8-16(11)13(18)10(14)5-2/h9-11H,4-8,14H2,1-3H3,(H,15,17)/t9-,10+,11+/m1/s1
InChIKey
VEBCSYAWQCGSMV-VWYCJHECSA-N
PubChem Compound ID
11579736
Target and Pathway
Target(s) Tripeptidyl-peptidase II Target Info Inhibitor [527857]
Reactome Antigen processing: Ubiquitination & Proteasome degradation
References
Ref 527857J Med Chem. 2005 Nov 17;48(23):7333-42.Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitors.
Ref 527857J Med Chem. 2005 Nov 17;48(23):7333-42.Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.